Methicillin-susceptible Staphylococcus aureus clone related to the early pandemic phage type 80/81 causing an outbreak among residents of three occupational centres in Barcelona, Spain  by Gasch, O. et al.
Methicillin-susceptible Staphylococcus aureus clone related to the early
pandemic phage type 80/81 causing an outbreak among residents of
three occupational centres in Barcelona, Spain
O. Gasch1, A. Hornero1, M. A. Domı´nguez2, A. Ferna´ndez2, C. Sua´rez1, S. Go´mez1, M. Camoez2, J. Linares2, J. Ariza1 and
M. Pujol1
Departments of 1) Infectious Diseases and 2) Microbiology, IDIBELL, Hospital Universitari de Bellvitge, Universitat de Barcelona, Barcelona, Spain
Abstract
In the 1950s an unusually virulent and transmissible penicillin-resistant Staphylococcus aureus clone harbouring Panton–Valentine leukoci-
din (PVL) genes, known as phage type 80/81 and subsequently identified as multilocus sequence type (ST) 30, emerged and caused
serious infections in hospitals and the community. We describe an outbreak of skin infections caused by a PVL-positive, methicillin-
susceptible S. aureus (MSSA) strain of ST1472, related to phage type 80/81, in three associated occupational centres. After identification
of the first patient an active case-finding strategy was initiated among the three centres. Epidemiological and clinical features were indis-
tinguishable from outbreaks currently caused by community-acquired methicillin-resistant S. aureus. The S. aureus was cultured and iden-
tified from nasal swabs and skin lesions by conventional methods; PVL was detected using a PCR assay. Pulsed-field gel electrophoresis
and DNA-array-based genotyping were applied to MSSA isolates. MSSA was identified in nasal swabs from 49 of 133 individuals (37%).
A single pulsed-field gel electrophoresis pattern, belonging to ST1472 (CC30) and PVL positivity, were detected in 20 individuals, includ-
ing eight of 18 skin cultures, i.e. 15% of the screened individuals were colonized by the epidemic strain. Nasal and cutaneous decontam-
ination with 5% nasal mupirocin ointment and 2% aqueous chlorhexidine was implemented for all individuals. Patients with active skin
infections were treated with a first-generation cephalosporin. General recommendations were made to prevent cross-transmission. No
new cases were reported over the following 90 days.
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Introduction
During the 1950s an unusually virulent and transmissible pen-
icillin-resistant Staphylococcus aureus clone harbouring Pan-
ton–Valentine leukocidin (PVL) genes, belonging to phage
type 80/81, emerged and caused serious skin and soft tissue
infections in hospitals and the community. This strain was
subsequently identified by multilocus sequence typing as
ST30 [1], belonging to clonal complex (CC) 30. The pan-
demic phage type 80/81 disappeared during the 1960s as
methicillin and its derivatives were used to treat penicillin-
resistant staphylococcal infections. Current outbreaks of
severe S. aureus skin and soft tissue infections detected
worldwide tend to be caused by community-acquired methi-
cillin-resistant strains (CA-MRSA) [2–4], although a few out-
breaks caused by methicillin-susceptible S. aureus (MSSA)
have recently been reported [5,6].
Panton–Valentine leukocidin was first described in 1894
[7] and was associated with skin and soft tissue infections in
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1932 [8]. It is a leukocytolytic toxin comprising two different
proteins, encoded by the lukS-PV and lukF-PV genes. It has
been related to recurrent severe skin infections, as well as
to necrotizing pneumonia in previously healthy people with-
out any contact with the health system [9]. Fewer than 5%
of S. aureus strains in Europe harbour the PVL genes,
although this percentage is much higher among strains caus-
ing cutaneous disease [10].
We describe an outbreak of skin and soft tissue infections
in three related occupational centres, caused by a PVL-posi-
tive MSSA strain belonging to CC30 and related to the for-
mer pandemic phage type 80/81.
Materials and Methods
Setting
A private institution in the Barcelona area with three associ-
ated therapeutic centres for teenagers and young adults with
behavioural disorders was studied. The three centres share
staff, comprising psychologists, nurses, social workers, educa-
tors, teachers and monitors. For the purposes of therapy,
residents usually move from one centre to another. Daily
attendance at the three centres is around 130 boys and girls
in a residential or outpatient setting.
Patients and methods
The first case was a social worker from one of the three
centres who attended our emergency department in April
2010 with a skin abscess. She reported having furuncles over
the past year and said there were other similar cases among
staff and residents of all three centres, where she had been
working for the last 2 years.
After identification of this case an active case-finding strat-
egy was established in the three centres where an outbreak
was suspected. A nasal swab was taken from all the residents
and staff. Samples from skin ulcers were also taken from
people with skin lesions.
Microbiology procedures
Swabs were plated onto coagulase–mannitol salt agar plates
(BBLTM Coagulase Mannitol Agar; BD, Madrid, Spain) and
inoculated into staphylococcal enrichment broth (BBLTM
brain–heart infusion; BD, plus 7% NaCl). After incubation at
35C for 24 h, broths were sub-cultured onto coagulase–
mannitol salt agar plates. Colonies suggestive of S. aureus
were identified by latex agglutination (Pastorex Staph-plus;
Bio-Rad Laboratories, Madrid, Spain) and DNase production
(DNase Test Agar; Biome´rieux, Marcy l’E´toile, France). Anti-
microbial susceptibility profiles were determined by the disk
diffusion method with respect to the following antibiotics:
penicillin, oxacillin, cefoxitin, erythromycin, clindamycin, gen-
tamicin, tobramycin, ciprofloxacin, rifampin, tetracycline, co-
trimoxazole, chloramphenicol, vancomycin, teicoplanin, phos-
phomycin, fusidic acid, quinupristin/dalphopristin, linezolid
and mupirocin. The criteria for antibiotic susceptibility were
those recommended by the Clinical and Laboratory Stan-
dards Institute [11]. Genes encoding class S (lukS-PV) and
class F (lukF-PV) proteins for PVL were amplified by PCR
assay in all S. aureus isolates [9].
Pulsed-field gel electrophoresis (PFGE) was performed on
all S. aureus isolates after SmaI restriction, following pub-
lished methodology [12]. Restriction patterns of the PFGE
were interpreted by visual inspection according to the crite-
ria of van Belkum et al. [13] and further analysed with the
FINGERPRINTINGTM II software, version 3.0 (BioRad Laborato-
ries, Inc., Madrid, Spain). The PFGE patterns were identified
using a dendrogram generated by the unweighted-pair group
method with arithmetic mean based on dice coefficients,
where optimization and band position tolerance were set at
0.5% and 1.3%, respectively. A similarity coefficient of 80%
was selected to define the patterns. [14] Multilocus sequence
typing (MLST) and DNA microarray hybridization (Staphy-
Type Kit, Alere Technologies Ltd, Jena, Germany; stripe ver-
sion) were carried out in representative strains of the main
clones, as described previously [15,16].
Interventions
To control further transmission, all residents and staff under-
went nasal and skin decontamination during the same week,
involving a daily shower (including hair) and using 2% aque-
ous chlorhexidine for 1 week and a nasal ointment with 5%
mupirocin in both nostrils (three times a day for 5 days).
During that week, they were all given general recommenda-
tions regarding increased hand washing, daily changing and
washing of towels, bedclothes and underwear in water at a
temperature of at least 60C, and instructions emphasizing
the importance of not sharing personal items. Primary-care
physicians were informed and passive surveillance (requesting
the reporting of relapsing skin infections) was performed.
The local department of health was also informed about the
investigation into the outbreak.
Results
Cultures from nasal swabs and active skin lesions were taken
from all the residents and staff of the three centres. Overall,
133 individuals (95 residents and 38 members of staff) aged
14–55 years were screened (57% males and 43% females).
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Among the residents, 22 (17%) came from other countries
(nine Colombia, three Romania, two Peru, and one each from
Nepal, Dominican Republic, Chile, Panama, Brazil, Mexico,
Argentina and Bolivia). None of those screened had any previ-
ous diseases of note, except for one patient with chronic
asthma, another with psoriasis and another with HIV infection
(acquired by vertical transmission). At the time of the screen-
ing or within the previous 2 years, 34 (26%) of them reported
skin lesions, which were described as ulcers, furuncles, cutane-
ous abscesses or folliculitis. Most of them had received sys-
temic treatment with beta-lactams or cotrimoxazole and/or
topical treatment with mupirocin or fusidic acid.
Cultures yielded MSSA in 49 of the 133 nasal swabs
(37%) and in eight skin ulcers from the nine patients with
cutaneous lesions at the time of screening. The OR for
S. aureus-colonized versus non-colonized for skin and soft
tissue infection during the outbreak period was 14.9 (95%
CI 5.3–41.9). Isolates were susceptible to all of the
antibiotics tested except for penicillin. MRSA was not
detected in any sample. The PVL test was positive in
MSSA isolates from 20 individuals, including all isolates
from skin ulcers (n = 8). Therefore, 20 (15%) of the 133
screened patients were colonized by a PVL-positive MSSA
(Table 1); OR (CC30 vs non-CC30 S. aureus) for skin and
soft tissue infection during the outbreak period: 3.0 (95%
CI 0.9–9.9).
Among PVL-positive MSSA strains isolated in both nasal
and skin lesions, a single PFGE pattern was observed (pattern
A). Seven PFGE restriction patterns (patterns B to H) were
found among the 27 PVL-negative MSSA isolates (Fig. 1).
Two patients were colonized by a PVL-negative variant of
PFGE type A. The PFGE patterns C and B clustered 14 and
eight patients, respectively. The unweighted-pair group
method with arithmetic mean analysis placed the PFGE pro-
files A and C in the same cluster with similarity higher than
80% (see Fig. 1).
The PVL-positive epidemic strain belonged to agr group
III. Multilocus sequence typing was performed on four strains
of PFGE type A (PVL-positive), two strains of PFGE type B
and two strains of PFGE type C. The epidemic strains (PVL-
positive PFGE type A strains) belonged to ST1472, a single
locus variant of ST30, defined by alleles arcc 2, aroe 2, glpf 2,
gmk 2, pta 6, tpi 3 and yqi 162. Strains of major PVL-negative
PFGE patterns C and B belonged to ST30 and ST45, respec-
tively.
TABLE 1. Demographic characteristics and treatment of patients with previous skin lesions and/or colonized by PVL produ-
cing Staphylococcus aureus (CC30)
Patient Gender/Age Role/Center Nationality Previous skin lesions Sample yielding CC30 MSSA Treatment
1 F/16 User/C Spain No NS NA
2 F/16 User/B Spain Yes Both Fusidic acid
3 M/16 User/A Spain No NS NA
4 M/21 Worker/C Spain Yes NS None
5 M/16 User/B Spain Yes NS NA
6 M/18 User/c Peru´ Yes Both Mupirocine
7 M/14 User/c Spain Yes NS Amoxicillin+ fusidic acid
8 M/16 User/c Spain Yes SL Cotrimoxazole
9(*) F/39 Worker/ABC Spain Yes SL Amoxicillin+ fusidic acid
10 M/25 Worker/B Spain No NS NA
11 F/15 User/A Peru´ No NS NA
12 M/49 Worker/B Spain No NS NA
13 F/16 User/C Spain Yes SL Mupirocine
14 F/16 User/B Spain No NS NA
15 M/15 User/A Spain Yes Both Cloxacilin
16 F/17 User/A Bolivia Yes NS NA
17 M/18 User/B Spain Yes NS Fusidic acid
18 F/16 User/B Spain Yes Both Cotrimoxazole
19 F/28 Worker/B Spain No NS NA
20 F/17 User/A Colombia Yes Both NA
(*)First case. M Male, F Female. NA Not aported. NS Nasal Swap. SL Skin lesion
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FIG. 1. Pulsed-field gel electrophoresis (PFGE) of SmaI macrores-
triction fragments of methicillin-susceptible S. aureus isolates. The
cut-off value for designing genotypes was set at 80%. For dendro-
gram construction tolerance was set at 1.25% and optimization at
0.5%.
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The DNA microarray analysis was performed on two sep-
arate PVL-positive PFGE type A strains which showed identi-
cal hybridization patterns. The epidemic strain showed a
single positive hybridization on gene blaZ among genes
encoding different antibiotic resistance markers. The epi-
demic strain carried the enterotoxin gene cluster (egc) com-
prising selo, selm, sei, seln, seg and selu genes. There were
also positive hybridization signals for the lukS/F-PVL, hlgA
(component A of c-haemolysin), hla (a-haemolysin), hlb
(b-haemolysin), hld (d-haemolysin) and sak (staphylokinase)
genes. The capsule was type 8. Genes for exfoliative toxins
A, B and D were negative, as was the gene coding for the
toxic shock syndrome toxin.
The microarray includes alleles coding for staphylococcal
superantigen-like proteins (set genes) from several sequenced
strains (MW0345, COL, Mu50, MW0382 and MRSA252).
The epidemic strain tested here harboured a complex of set
genes analogous to the set alleles found in strain MRSA252.
Strain MRSA252 belongs to ST36 (alleles arcc 2, aroe 2, glpf 2,
gmk 2, pta 3, tpi 3 and yqi 2), a single locus variant of ST30.
Patients with active skin lesions were treated for 2 weeks
with a first-generation cephalosporin. After treatment the
decontamination strategy was initiated for all staff and resi-
dents, with no new cases of skin infections appearing over
the following 90 days.
Discussion
Our study is a comprehensive description of an outbreak of
skin and soft tissue infections caused by a PVL-positive MSSA
strain belonging to CC30 and related to the former pan-
demic phage type 80/81. Some aspects of our experience
require more detailed comment.
From an epidemiological and clinical perspective the out-
break affected a closed community of teenagers and young
adults. This age group has close contact and share activities
and personal items that facilitate the transmission of an epi-
demic strain. One noteworthy finding was the high estimated
attack rate of 26%, which illustrates a great ability of this
strain to disseminate, as had been reported for MSSA phage
type 80/81 in the early 1950s. Of note, the OR of CC30-col-
onized patients (compared with those patients colonized by
other clones of S. aureus) for SSTI was three. However, it
must be pointed out that it might be underestimated by the
effect of treatment received by patients with lesions before
the detection and study of the outbreak, which might achieve
in some cases a persistent decontamination.
Although CA-MRSA is still infrequent in Spain it is being
increasingly reported. The clinical and epidemiological fea-
tures of the outbreak described here were indistinguishable
from those reported for CA-MRSA outbreaks [17], and in
fact the latter was our initial suspicion after seeing the first
case. The skin lesions reported by residents and staff were
predominantly severe and relapsing furunculosis, similar to
those caused by CA-MRSA harbouring PVL in community
settings such as football teams or schools.
Given the lack of specific recommendations for preventing
epidemic MSSA infections, and in accordance with previous
experience with MRSA infections [18,19], we advised the
three centres of the need to perform a universal and active
decontamination with mupirocin ointment and aqueous
chlorhexidine for all staff and residents, irrespective of their
carrier status for the epidemic strain. A number of general
hygiene measures were also recommended to avoid trans-
mission. As a result, no other case of MSSA infection was
observed over the following 3 months.
The strain cultures in the furuncle from the first patient
were identified as the epidemic MSSA strain, The multilocus
sequence typing analysis revealed that it belonged to the
CC30 lineage (ST1472) and carried a set of alleles identical
to those of reference strain MRSA252, which also belongs to
CC30 (ST36). The founder of CC30 is ST30, the same as
that of the former pandemic phage type 80/81. As in our
experience, phage type 80/81 was a highly transmissible
strain that caused outbreaks of severe skin disease during
the 1950s [1,20]. It was shown to be very invasive and one
study reported that a third of nasal carriers of phage type
80/81 who were admitted to hospital developed septicaemia,
compared with <5% of those colonized by other strains [21].
The isolation of this strain subsequently decreased, which
could be related to the introduction of penicillinase-resistant
b-lactams in the 1960s.
The MSSA strain described here had the most prevalent
susceptibility pattern in Spain (resistance to penicillin, suscep-
tibility to other tested antibiotics) [22], and had no other
SCCmec-associated genes, as this has been screened with
the DNA microarray hybridization. This differs from other
reported clusters caused by multi-resistant MSSA strains, in
which mecA remnants were found. These reports [6,23,24]
concluded that their findings were the result of an S. aureus
strain that had previously lost the mecA gen.
A regional distribution of S. aureus clones causing infec-
tions has been observed [25]. For instance, whereas most
PVL S. aureus-related infections in the USA have been caused
by ST8 USA300 CA-MRSA strains [20,25], the most preva-
lent strains in Europe belong to ST8, ST80, ST30 and 121
[25–28]. Hence, in contrast to what is seen in the USA,
most of the infections caused by PVL-producing strains in
Europe are MSSA. However, this scenario is probably over-
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looked because no routine test is usually performed to
detect PVL expression [29–31].
In summary, the paper describes an outbreak caused by a
PVL-positive MSSA strain related to the former pandemic
phage type 80/81. All the characteristics were indistinguish-
able from those of CA-MRSA outbreaks. The outbreak was
controlled after active nasal and cutaneous decontamination.
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